Shalby Q1 results FY26: Revenue rises, profit falls

Shalby Q1 FY26 results: the key takeaway

Shalby Limited’s June-quarter (Q1) update shows steady top-line growth but weaker profitability versus the year-ago period. Total revenue for the quarter stood at ₹296.43 crore, up 6.29% year-on-year (YoY) and higher sequentially as well. Net income, however, was lower at ₹8.92 crore compared with the same quarter last year, and diluted normalised EPS declined to ₹0.83.

Alongside financial updates, Shalby also disclosed compliance and corporate actions, including a compliance certificate filing under SEBI’s depository regulations for the quarter ended June 30, 2026. The company’s results calendar and earnings-call schedule were also referenced across filings and updates.

Revenue and operating line: what the quarter showed

For the June quarter, Shalby reported total revenue of ₹296.43 crore versus ₹278.89 crore in the year-ago quarter, reflecting 6.29% YoY growth. Sequentially, revenue was higher than the March-quarter revenue of ₹287.45 crore as shown in the provided quarterly table.

On the operating line, the table lists operating income at ₹25.02 crore for the June quarter, compared with ₹10.87 crore in the March quarter and ₹28.84 crore in the year-ago quarter. Separately, the provided text also states “Operating Profit” of ₹16.38 crore for the quarter, up 2.44% QoQ from ₹15.99 crore, and down 8.08% YoY. These figures are presented as reported in the source data.

Costs and expenses: operating expense remains elevated

Total operating expense for the June quarter was ₹271.41 crore, compared with ₹250.05 crore in the year-ago quarter. This reflects an 8.54% YoY increase as per the table.

Within expenses, selling, general and administrative (SG&A) expenses were ₹46.51 crore for the quarter. Other operating expenses totalled ₹29.51 crore, lower than ₹36.51 crore in the March quarter.

Depreciation and amortisation was largely stable at ₹16.52 crore for the June quarter, broadly similar to ₹16.37 crore in the year-ago period.

Profitability: net income and EPS versus last year

Net income for the June quarter stood at ₹8.92 crore, lower than ₹15.66 crore in the year-ago quarter. Net income before taxes was ₹22.65 crore versus ₹30.41 crore last year, indicating a weaker pre-tax outcome despite higher revenue.

Diluted normalised EPS was ₹0.83 for the June quarter, down from ₹1.38 in the year-ago period.

The broader dataset also references consolidated Q1 FY26 metrics expressed in millions of rupees. On a normalised basis, consolidated revenue is stated as ₹296.43 crore (₹2,964.26 million) and consolidated PAT as ₹7.68 crore (₹76.78 million). Standalone revenue is cited at ₹236.65 crore (₹2,366.54 million) and standalone PAT at ₹25.70 crore (₹256.95 million).

March 2026 quarter context: sharp profit improvement sequentially

Shalby’s March 2026 quarter results were also referenced in the source text. The company reported consolidated net profit of ₹18.32 crore in the quarter ended March 2026, compared with a net loss of ₹11.02 crore in the quarter ended March 2025.

Sales for the March 2026 quarter were reported at ₹287.45 crore, up 8.52% versus ₹264.89 crore in the previous-year quarter (as stated). For the full year ended March 2026, net profit rose 501.13% to ₹37.39 crore compared with ₹6.22 crore in the previous year.

Operational metrics and business mix: what was highlighted

The provided dataset includes additional operating indicators for the June quarter. It states that over 9,000 surgeries were performed and inpatient count saw a slight decrease. ARPOB (average revenue per occupied bed) increased 5.3% to ₹45,673, while occupancy rate dropped to 45%.

Updates also mention Shalby MedTech performance, including revenue of ₹30.8 crore in Q1 FY26 versus ₹17.4 crore in Q1 FY25, reflecting 74.2% YoY growth, along with commentary that the segment moved closer to break-even.

Compliance and corporate disclosures

Shalby Limited said it submitted the compliance certificate required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026.

The company also submitted to BSE the shareholding pattern for the period ended June 30, 2026, as referenced in the input text. Separately, another update referenced the re-appointment of an independent director and subscription to subsidiary PK Healthcare’s rights issue, in the context of Q3 FY26 results.

Results calendar and scheduled events

The dataset lists multiple quarterly-results announcement dates, including Aug 12, 2026; May 27, 2026; Feb 11, 2026; and Nov 13, 2025. It also states the board of directors meeting was scheduled on May 27, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026.

An earnings conference call was scheduled for Friday, May 29, 2026, at 5:00 PM IST to discuss Q4 FY2026 earnings. Another note states that Q1 results for the quarter ended June 30, 2025 were approved by the board on Aug 13, 2025 and published on Aug 14, 2025.

Key numbers at a glance

Market snapshot: latest quoted price

The input data cites Shalby’s current price at ₹160.09.

What to watch from here

With revenue growth visible in the June-quarter numbers, investor focus typically shifts to how operating costs, occupancy trends, and segment mix translate into consistent profitability. The company has also outlined dates for results-related announcements, including the Aug 12, 2026 schedule referenced in the dataset.

Future updates to watch will include any further disclosures around board decisions, earnings calls, and segment performance metrics such as occupancy and ARPOB that were highlighted alongside the financials.